Synthesis and hypolipidaemic evaluation of a series of alpha-asarone analogues related to clofibrate in mice.
A series of alpha-asarone analogues related to clofibrate, containing an acetic acid group at C-2 of the aromatic ring, has been prepared as the acids or as the ethyl and methyl esters. The corresponding alcohols were also synthesized by reduction of the ethyl esters. The compounds were examined in hyperlipidaemic male mice to evaluate their ability to modify serum lipoprotein cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides after oral administration of 40 and 80 mg kg(-1) for 6 days. Except for methyl 2-methoxy-5-nitro-4-(2-propenyl)phenoxyacetate at either dose, these clofibrate-related phenoxyacetic acid derivatives were found to have significant hypocholesterolaemic activity. Levels of low-density lipoprotein cholesterol and triglycerides were significantly reduced and those of high-density lipoprotein cholesterol were elevated. 2-Methoxy-5-nitro-4-(2-propenyl)phenoxyacetic acid was active at both doses in all the tests. Clofibrate (150 mg kg(-1)) was more potent at reducing low-density lipoprotein cholesterol. No activity was detected for the alcohol derivatives. These preliminary results suggest that this class of compound might have more promise as potential hypolipidaemic agents than other alpha-asarone derivatives. Further investigation and characterization should be performed to determine the mode of action of these agents on lipid metabolism.
Labarrios
F
F
Department of Organic Chemistry, National School of Biological Sciences, National Polytechnic Institute, México, DF, México.
Garduño
L
L
Vidal
M R
MR
Garcia
R
R
Salazar
M
M
Martinez
E
E
Diaz
F
F
Chamorro
G
G
Tamariz
J
J
D000081248:Allylbenzene Derivatives; D000818:Animals; D000840:Anisoles / Q000138:chemical synthesis / Q000494:pharmacology*; D002994:Clofibrate / Q000494:pharmacology*; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects*; D008297:Male; D051379:Mice; D010642:Phenoxyacetates / Q000138:chemical synthesis / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D014280:Triglycerides / Q000097:blood*
D000081248:Allylbenzene Derivatives; D000840:Anisoles; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D010642:Phenoxyacetates; D014280:Triglycerides; C012195:asarone; D002994:Clofibrate